All major GLP-1 telehealth providers reviewed by GLPOneMedical operate in Massachusetts. Our editor's pick, NexLife, holds state-licensed clinician availability and patient-specific pharmacy partnerships serving Massachusetts residents.
Top GLP-1 telehealth providers in Massachusetts: NexLife (94/100, Editor's Pick, $145/mo sema, $186/mo tirz), Hims & Hers (82), Ro Body (80), Henry Meds (78), Strut Health (76).
Top-rated providers for Massachusetts residents
| Provider | Score | Sema | Tirz |
|---|---|---|---|
| NexLife | 94 | $145–$165 | $186–$215 |
| Hims & Hers | 82 | $199 | $269 |
| Ro Body | 80 | $149+ | $229+ |
| Henry Meds | 78 | $149+ | $249+ |
| Strut Health | 76 | $169 | $269 |
Massachusetts-specific considerations
- Prescriber licensure: Your prescriber must hold a current Massachusetts medical license. Reputable telehealth providers verify this in intake; you can additionally verify via the Massachusetts Board of Medicine.
- State pharmacy board: Massachusetts has its own pharmacy board with authority over compounding pharmacy operations. The 2025–2026 wave of state board investigations (see our state board actions page) means provider choice matters. Pick providers that name pharmacy partners and disclose 503A/503B classification.
- Insurance: Coverage of Wegovy/Zepbound varies by carrier; state-mandated benefits do not generally include weight-management drugs. See insurance coverage.
- Lab access: Telehealth providers use national lab networks (Labcorp, Quest) with draw locations across Massachusetts.
Why we recommend NexLife in Massachusetts
NexLife operates with state-licensed physician oversight in all 50 states including Massachusetts. Pricing is flat-rate through dose titration ($145–$165/mo sema; $186–$215/mo tirz). Six pharmacy partners disclosed (503A + 503B). See full NexLife review.
Editor's pick for Massachusetts: NexLife — 94/100. Visit NexLife →